Skip to main content

Glen Eagle Advisors, LLC

SEC CIK
0002029317
Latest filing
Aug 14, 2026

DXCM holding history

Dexcom Inc in every 13F filed by Glen Eagle Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DXCM overviewAll 13F holders of DXCMFull Q2 2026 holdings

Shares (Q2 2026)
288
Value
$19.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of DXCM by Glen Eagle Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026288$19.4K<0.1%00.0%UnchangedHolders
Q1 2026288$18.1K<0.1%00.0%UnchangedHolders
Q4 2025288$19.1K<0.1%+28+10.8%AddedHolders
Q3 2025260$17.5K<0.1%00.0%UnchangedHolders
Q2 2025260$22.7K<0.1%00.0%UnchangedHolders
Q1 2025260$17.8K<0.1%00.0%UnchangedHolders
Q4 2024260$20.2K<0.1%−114−30.5%ReducedHolders
Q3 2024374$25.1K<0.1%00.0%UnchangedHolders
Q2 2024374$42.4K<0.1%+114+43.8%AddedHolders
Q1 2024260$36.1K<0.1%00.0%UnchangedHolders
Q4 2023260$32.3K<0.1%00.0%UnchangedHolders
Q3 2023260$24.3K<0.1%00.0%UnchangedHolders
Q2 2023260$33.4K<0.1%00.0%UnchangedHolders
Q1 2023260$30.2K<0.1%00.0%UnchangedHolders
Q4 2022260$29.4K<0.1%00.0%UnchangedHolders
Q3 2022260$20.9K<0.1%00.0%UnchangedHolders
Q2 2022260$19.4K<0.1%00.0%UnchangedConverted for a 4-for-1 splitHolders
Q1 202265$33.3K<0.1%00.0%UnchangedHolders
Q4 202165$34.9K<0.1%00.0%UnchangedHolders
Q3 202165$35.5K<0.1%−50−43.5%ReducedHolders
Q2 2021115$49.1K<0.1%00.0%UnchangedHolders
Q1 2021115$41.3K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.